Cargando…
Long-Term Tolvaptan Treatment in Refractory Heart Failure
Background: The vasopressin type-2 receptor antagonist tolvaptan is an essential tool in the management of decompensated heart failure (HF) in the inpatient setting for short-term use with careful monitoring. There is conflicting evidence, however, for its long-term use. Methods and Results: In this...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Circulation Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897549/ https://www.ncbi.nlm.nih.gov/pubmed/33693080 http://dx.doi.org/10.1253/circrep.CR-19-0064 |